BRINGHEN, Sara
BRINGHEN, Sara
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
2016-01-01 Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
2013-01-01 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
2013-01-01 Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A
Approach to the Older Adult With Multiple Myeloma
2019-01-01 Mina, Roberto; Bringhen, Sara; Wildes, Tanya M; Zweegman, Sonja; Rosko, Ashley E
Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study
2017-01-01 Grammatico S, Bringhen S, Vozella F, Siniscalchi A, Boccadoro M, Petrucci MT.
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.
2014-01-01 Morabito F;Bringhen S;Larocca A;Wijermans P;Mateos M V;Gimsing P;Mazzone C;Gottardi D;Omedè P;Zweegman S;Lahuerta J J;Zambello R;Musto P;Magarotto V;Schaafsma M;Oriol A;Juliusson G;Cerrato C;Catalano L;Gentile M;Turel A I;Liberati A M;Cavalli M;Rossi D;Passera R;Rosso S;Beksac M;Cavo M;Waage A;San-Miguel J;Boccadoro M;Sonneveld P;Palumbo A;Offidani M
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
2014-01-01 Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
2018-01-01 Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies
2021-01-01 Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study.
2014-01-01 Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A
Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study
2023-01-01 Astarita, Anna; Mingrone, Giulia; Airale, Lorenzo; Cesareo, Marco; Colomba, Anna; Catarinella, Cinzia; Leone, Dario; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Milan, Alberto; Vallelonga, Fabrizio
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma
2019-01-01 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant
2022-01-01 Giaccone L.; Brunello L.; Londono J.S.; Scaldaferri M.; Cerrano M.; Redoglia V.; Omede P.; Lia G.; Massaia M.; Ferrero D.; Cavallo F.; Bringhen S.; Leone S.; Cattel F.; Francisci T.; Tassi V.; Evangelista A.; Boccadoro M.; Bruno B.
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma
2014-01-01 Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A.
Determining treatment intensity in elderly patients with multiple myeloma
2018-01-01 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, nordic and turkish myeloma study groups
2015-01-01 Beksac, Meral; Waage, Anders; Bringhen, Sara; Kristinsson, Sigurdur Y.; Sucak, Gülsan Türköz; Gimsing, Peter; Lupparelli, Giulia; Firatli-Tuʇlular, Tulin; Juliusson, Gunnar; Turesson, Ingemar; Palumbo, Antonio
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021-01-01 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis
2018-01-01 Bringhen, Sara; Offidani, Massimo; Palmieri, Salvatore; Pisani, Francesco; Rizzi, Rita; Spada, Stefano; Evangelista, Andrea; Di Renzo, Nicola; Musto, Pellegrino; Marcatti, Magda; Vallone, Roberto; Storti, Sergio; Bernardini, Annalisa; Centurioni, Riccardo; Aitini, Enrico; Palmas, Angelo; Annibali, Ombretta; Angelucci, Emanuele; Ferrando, Paola; Baraldi, Anna; Rocco, Stefano; Andriani, Alessandro; Siniscalchi, Agostina; De Stefano, Valerio; Meneghini, Vittorio; Palumbo, Antonio; Grammatico, Sara; Boccadoro, Mario; Larocca, Alessandra*
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
| A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma | 2016 | Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A | |
| A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients | 2013 | Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A | |
| Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials | 2013 | Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A | |
| Approach to the Older Adult With Multiple Myeloma | 2019 | Mina, Roberto; Bringhen, Sara; Wildes, Tanya M; Zweegman, Sonja; Rosko, Ashley E | |
| Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study | 2017 | Grammatico S, Bringhen S, Vozella F, Siniscalchi A, Boccadoro M, Petrucci MT. | |
| Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study. | 2014 | Morabito F;Bringhen S;Larocca A;Wijermans P;Mateos M V;Gimsing P;Mazzone C;Gottardi D;Omedè P;Zweegman S;Lahuerta J J;Zambello R;Musto P;Magarotto V;Schaafsma M;Oriol A;Juliusson G;Cerrato C;Catalano L;Gentile M;Turel A I;Liberati A M;Cavalli M;Rossi D;Passera R;Rosso S;Beksac M;Cavo M;Waage A;San-Miguel J;Boccadoro M;Sonneveld P;Palumbo A;Offidani M | |
| Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. | 2014 | Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M | |
| Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) | 2018 | Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt | |
| Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies | 2021 | Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara | |
| Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. | 2014 | Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A | |
| Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study | 2023 | Astarita, Anna; Mingrone, Giulia; Airale, Lorenzo; Cesareo, Marco; Colomba, Anna; Catarinella, Cinzia; Leone, Dario; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Milan, Alberto; Vallelonga, Fabrizio | |
| Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma | 2019 | D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F. | |
| Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant | 2022 | Giaccone L.; Brunello L.; Londono J.S.; Scaldaferri M.; Cerrano M.; Redoglia V.; Omede P.; Lia G.; Massaia M.; Ferrero D.; Cavallo F.; Bringhen S.; Leone S.; Cattel F.; Francisci T.; Tassi V.; Evangelista A.; Boccadoro M.; Bruno B. | |
| Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma | 2014 | Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A. | |
| Determining treatment intensity in elderly patients with multiple myeloma | 2018 | Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S. | |
| Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, nordic and turkish myeloma study groups | 2015 | Beksac, Meral; Waage, Anders; Bringhen, Sara; Kristinsson, Sigurdur Y.; Sucak, Gülsan Türköz; Gimsing, Peter; Lupparelli, Giulia; Firatli-Tuʇlular, Tulin; Juliusson, Gunnar; Turesson, Ingemar; Palumbo, Antonio | |
| Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma | 2021 | Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara | |
| Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis | 2018 | Bringhen, Sara; Offidani, Massimo; Palmieri, Salvatore; Pisani, Francesco; Rizzi, Rita; Spada, Stefano; Evangelista, Andrea; Di Renzo, Nicola; Musto, Pellegrino; Marcatti, Magda; Vallone, Roberto; Storti, Sergio; Bernardini, Annalisa; Centurioni, Riccardo; Aitini, Enrico; Palmas, Angelo; Annibali, Ombretta; Angelucci, Emanuele; Ferrando, Paola; Baraldi, Anna; Rocco, Stefano; Andriani, Alessandro; Siniscalchi, Agostina; De Stefano, Valerio; Meneghini, Vittorio; Palumbo, Antonio; Grammatico, Sara; Boccadoro, Mario; Larocca, Alessandra* | |
| Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca |